• There are no suggestions because the search field is empty.
  • Careers
  • Media
  • Investors
  • Contact us
Company
Company
Purpose
Strategy
Leadership
History
Locations
Offering
Offering
Drug Substances
Exclusive synthesis API portfolio Reference standards Preclinical and early-phase development Alkaloid raw materials extraction
Drug Products
Oral solid dosage forms Sterile injectables Ophthalmics Inhalation products Viral vectors
Technologies
Sustainability
Sustainability
People
Environment
Integrity
Quality
Community engagement
Risk management
Insights

What are you
looking for?

Company
Purpose
Strategy
Leadership
History
Locations
Offering
Drug Substances
Exclusive synthesis API portfolio Reference standards Preclinical and early-phase development Alkaloid raw materials extraction
Drug Products
Oral solid dosage forms Sterile injectables Ophthalmics Inhalation products Viral vectors
Technologies
Sustainability
People
Environment
Integrity
Quality
Community engagement
Risk management
Insights
  • Careers
  • Media
  • Investors
  • Contact us

Insights

See our event recap

Filter by tags
Technology Sustainability Drug Products Early-phase development Oral solid dosage form
Technology Sustainability Drug Products Early-phase development Oral solid dosage form Regulatory support Scale-up
NEW
07/8/2026
Early-phase development Regulatory support

Navigating the complex route to regulatory compliance, from preclinical to market

Read article
Recent
Jun 22, 2026
Scale-up Drug Products

The need for speed: Early-stage dosage form development

Apr 2, 2026

Accelerate to win: The challenges of dosage form development

Mar 23, 2026

From lab to launch: Cutting time in pharmaceutical development

Subscribe for more expert insights

 

All posts
Dec 8, 2025

Unlocking the potential of capsule-based dry powder inhalers: From development to commercialization

Nov 18, 2025

White label stocking: Enhancing supply chain flexibility and speed to market

Oct 2, 2025

4 reasons early-phase drug development in the US gives US pharma a competitive edge

Sep 16, 2025
Technology

Spray drying: The key to maximize drug solubility and bioavailability

Jul 10, 2025

Accelerate drug development with phase-appropriate thinking

May 12, 2025

Small molecules, growing complexities: Navigating shifts in supply chain and manufacturing

1 2 3 4 5
Oct 30, 2025

Video: Insights from Chief Scientific Officer Stefan Randl at CPHI Frankfurt 2025

Sign up to stay up to date on Siegfried and our business performance.

expect more

 

Siegfried AG
Untere Brühlstrasse 4
4800 Zofingen, Switzerland

+41 62 746 11 11 info@siegfried.ch
About us
  • Our company
  • Sustainability
  • Media
  • Investors
  • Careers
Helpful resources
  • Expert insights
  • News archive
  • Reports
  • Terms and conditions
Offering
  • Drug Substances
  • Drug Products
  • Technologies

2024 © Siegfried Holding AG

Follow us on LinkedIn